Clinical Trial

Mobile Outreach Screening of High-Risk Human Papillomavirus Infection in Women with Limited Access to Health Services in Seine-Saint-Denis (greater Paris Area, France)

Study acronym: PAPMOBILE
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 24, 2024 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study is a prospective cervical cancer screening intervention in the nonclinical setting of a mobile testing unit in a vehicle, using point-of-care HPV PCR tests with self-collected vaginal swabs. It is designed for women with limited access to healthcare and prevention in underprivileged municipalities in the greater Paris area (Seine-Saint-Denis department, detailed in Annexe 3). HPV positive participants will receive counseiling and guidance to help them find a healthcare professional to take care of their needs
Trial Details
NCT Number NCT06656611
Lead Sponsor Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Collaborators: Hospital Avicenne, National Cancer Institute, France, INSERM UMR S 1136, Institut National de la Santé Et de la Recherche Médicale, France
Conditions Women's Health: Cervical Neoplasm
Enrollment 700 participants
Start Date 2024-12-01
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-24